June 22 (Reuters) - Nikkei:
* Hisamitsu Pharmaceutical's group operating profit appears
to have declined 13% on the year to just under 5 billion yen for
March-May quarter - Nikkei
* Hisamitsu Pharmaceutical's sales for March-May quarter are
seen down 8% at about 35 billion yen - Nikkei
* Hisamitsu Pharmaceutical Co Inc will likely maintain its
forecast for the full year ending February 2018 - Nikkei
Source text - (http://s.nikkei.com/2tSIwsz)
Further company coverage: 4530.T
((Bangalore.newsroom@thomsonreuters.com;))